[Federal Register Volume 83, Number 59 (Tuesday, March 27, 2018)]
[Rules and Regulations]
[Pages 13105-13106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-06065]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 5

[Docket No. FDA-2018-N-0011]


Revision of Organization; Technical Amendment

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; technical amendment.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is amending 
its regulations to reflect organizational change for the Office of 
Regulatory Policy, Center for Drug Evaluation and Research (CDER), 
Office of Medical Products and Tobacco. FDA is taking this action to 
ensure accuracy and clarity in the Agency's regulations.

DATES: This rule is effective March 27, 2018.

FOR FURTHER INFORMATION CONTACT: Florine Purdie, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave. Bldg. 51, Rm. 6248, Silver Spring, MD 20993-0002, 301-
796-3601.

SUPPLEMENTARY INFORMATION: FDA is amending 21 CFR 5.1100 to update the 
organizational information for the Office of Regulatory Policy, CDER, 
Office of Medical Products and Tobacco.
    Publication of this document constitutes final action on this 
change under the Administrative Procedure Act (5 U.S.C. 553). FDA has 
determined that notice and public comment are unnecessary because this 
amendment to the regulations provides only a technical change to update 
the

[[Page 13106]]

organizational information for the Office of Regulatory Policy, CDER, 
Office of Medical Products and Tobacco.

List of Subjects in 21 CFR Part 5

    Authority delegations (Government agencies), Imports, Organization 
and functions (Government agencies).

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
5 is amended as follows:

PART 5--ORGANIZATION

0
1. The authority citation for part 5 continues to read as follows:

    Authority:  5 U.S.C. 552; 21 U.S.C. 301-397.


Sec.  5.1100   [Amended]

0
2. In Sec.  5.1100, under the heading ``OFFICE OF MEDICAL PRODUCTS AND 
TOBACCO'', under ``Office of Regulatory Policy.'', under ``Division of 
Regulatory Policy III.'', add the words ``Division of Regulatory Policy 
IV.''.

    Dated: March 21, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-06065 Filed 3-26-18; 8:45 am]
 BILLING CODE 4164-01-P


